UCSF PANC Cyst Registry

Description

Pancreatic cysts are found incidentally on 15-50% of CT and MRIs for all indications and their prevalence is increasing. Many of these cysts may be precursors to pancreatic cancer, and thus pose a substantial risk, however, the vast majority are benign. Increased detection of pancreatic cysts provides an opportunity to diagnose pancreatic malignancy at an early, curable stage yet also increases the potential to over-treat clinically insignificant lesions. This presents a clinical challenge to prevent unnecessary resection of indolent disease, with associated risks of infections, bleeding, diabetes, and costly disability. Unfortunately, there is little information on the epidemiology and natural history of pancreatic cysts to help guide management.

Conditions

Pancreatic Cyst, Pancreatic Neoplasms, Pancreatic Cancer, Pancreatic Diseases, Pancreatic Intraductal Papillary Mucinous Neoplasm, Intraductal Papillary Mucinous Neoplasm, Pancreatic Ductal Adenocarcinoma, Mucinous Cyst

Study Overview

Study Details

Study overview

Pancreatic cysts are found incidentally on 15-50% of CT and MRIs for all indications and their prevalence is increasing. Many of these cysts may be precursors to pancreatic cancer, and thus pose a substantial risk, however, the vast majority are benign. Increased detection of pancreatic cysts provides an opportunity to diagnose pancreatic malignancy at an early, curable stage yet also increases the potential to over-treat clinically insignificant lesions. This presents a clinical challenge to prevent unnecessary resection of indolent disease, with associated risks of infections, bleeding, diabetes, and costly disability. Unfortunately, there is little information on the epidemiology and natural history of pancreatic cysts to help guide management.

Population-Based Analysis of Neoplastic Changes in Cystic Lesions of the Pancreas.

UCSF PANC Cyst Registry

Condition
Pancreatic Cyst
Intervention / Treatment

-

Contacts and Locations

San Francisco

University of California, San Francisco, San Francisco, California, United States, 94143

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

For general information about clinical research, read Learn About Studies.

Eligibility Criteria

  • * The inclusion criteria for this study are intentionally broad. Eligible patients for prospective enrollment will include
  • * Adults ≥ 30 years of age
  • * Have a radiographic or endoscopic diagnosis of at least one pancreatic cysts regardless of treatment status,
  • * No history of pancreatic cancer,
  • * Can speak and read English,
  • * Have access to a computer or mobile device (\~95% of U.S. population); and
  • * Are able to complete an electronic informed consent.
  • * Patients who don't speak English,
  • * Don't have access to a computer or mobile device; or
  • * Patients who have a cancer diagnosis.

Ages Eligible for Study

18 Years to

Sexes Eligible for Study

ALL

Accepts Healthy Volunteers

No

Collaborators and Investigators

University of California, San Francisco,

Kimberly S Kirkwood, MD, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Paige M Bracci, PhD, MPH, MS, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

2030-01-01